The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments ...

Tirzepatide, a medication sold under the names Mounjaro for diabetes and Zepbound for weight loss, has shown impressive results in helping people avoid developing diabetes. A new study found that it ...

Viking Therapeutics is developing a weight loss medicine ... approved by the Food and Drug Administration is Eli Lilly's tirzepatide, a therapy that is smashing pharmaceutical industry sales records, ...

Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO stock is a buy.

The top China executive of US pharmaceutical company Eli Lilly and Co said on Wednesday that the company aims to make its ...

A new partnership between Walmart and drug maker Eli Lily will make it easier for people to access the super-popular weight loss drug Zepbound. Starting in mid-November, customers with a prescription ...

Walmart Pharmacies to offer weight-loss drug making obesity treatment more accessible for millions nationwide.

Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating ...

Plus, the Trump administration is expected to release finalized Medicare payment rules for doctors and hospitals as soon as next week.